Five drugmakers and distributors are offering $22 billion in cash as well as drugs and services they value at $28 billion to resolve lawsuits alleging the industry helped fuel the U.S. opioid crisis, two sources familiar with the matter told Reuters on Wednesday.
from Reuters: Top News https://reut.rs/32qEMjS
via IFTTT
from Reuters: Top News https://reut.rs/32qEMjS
via IFTTT